BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Chromosome banding analysis is still used as a standard to detect the t(9;22)(q34;q11) or BCR-ABL rearrangement, to monitor treatment response in e.g., chronic myeloid leukemia.